NCT00663052 Study Evaluating Etanercept for the Treatment of Moderate to Severe Psoriasis Status COMPLETED Phase PHASE4
NCT00658788 Safety & Effectiveness of Clobex Spray, Followed by Calcitriol Ointment in Management of Plaque Psoriasis Status COMPLETED Phase PHASE3
NCT00655564 Long-Term One Year Use of Alefacept (Amevive®) in Moderate to Severe Chronic Plaque Type Psoriasis Status COMPLETED Phase PHASE4
NCT00647400 Adalimumab in Adult Japanese Subjects With Psoriasis Status COMPLETED Phase PHASE2/PHASE3
NCT00646191 Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis Status COMPLETED Phase PHASE2
NCT00645905 Study of Two Dosing Schedules of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis Status COMPLETED Phase PHASE2
NCT00645892 Extension Study of Two Dosing Schedules of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis Status COMPLETED Phase PHASE2
NCT00645814 Multicenter Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis Status COMPLETED Phase PHASE2
NCT00643526 A Study to Test the Design, Functionality, and Ergonomic Features of the Autoinjector Status COMPLETED Phase EARLY_PHASE1
NCT00617994 Open Label, Safety and Efficacy Study of Topical Investigational Drug to Treat Patients With Psoriasis Status COMPLETED Phase PHASE2
NCT00606450 Double-Blind, Randomized, Placebo-controlled Comparison of CC-10004 in Subjects With Moderate to Severe Plaque Type Psoriasis Status COMPLETED Phase PHASE2
NCT00604682 Open-Label,Single-Arm Pilot Study to Evaluate the Pharmacodynamics, Pharmacokinetics, Safety, and Preliminary Efficacy of CC1004 in Subjects With Severe Plaque Type Psoriasis Status COMPLETED Phase PHASE2
NCT00602823 Genomic Study for the Prediction of Efficacy and Adverse Effects of CD11a Monoclonal Antibodies(Raptiva) Status COMPLETED Phase N/A
NCT00585650 Study of Tumor Necrosis Factor Receptor Fusion Protein Etanercept (Enbrel) in Psoriasis of the Hands and/or Feet Status COMPLETED Phase PHASE1/PHASE2
NCT00581555 Evaluation of Etanercept in Patients With Plaque Psoriasis After Stopping Ciclosporin Therapy Status COMPLETED Phase PHASE4
NCT00581165 Study Evaluating Safety of Etanercept in Treatment of Patients With Moderate to Severe Psoriasiswith Etanercept Status COMPLETED Phase PHASE4
NCT00578370 Efficacy and Tolerability Study of Topical Ciclosporin in a Psoriasis Plaque Test Status COMPLETED Phase PHASE1/PHASE2
NCT00566722 Open Label Study of Adalimumab in Subjects Who Have a Sub-optimal Response to Systemic Therapy or Phototherapy Status COMPLETED Phase PHASE3